Since TANs work as immunosuppressive cells through the production of TGF-β [92] and inducible nitric oxide synthase (iNOS) [93] in the tumor microenvironment, they drive tumor progression in skin cancer [92,93]. Here, TGFB1 is linked to neoplasm.